New once-a-day antimalarial combination therapy as effective as the twice-a-day gold standard regimen
Thursday, April 22, 2010 - 17:55
in Health & Medicine
The new antimalarial combination therapy pyronaridine-artesunate is as effective as the gold standard treatment of artemether-lumefantrine. Furthermore, the new therapy only needs to be taken once daily, compared to twice daily for the gold standard regimen. The findings are reported in an Article in this week's Lancet, written by Dr Isabelle Borghini-Fuhrer, Medicines for Malaria Venture, Geneva, Switzerland, and colleagues.